Supriya Lifescience Limited has informed the Exchange about Schedule of Analysts/Institutional Investor Meet/Con. Call Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirement...
Date: November 3, 2022
To,
BSE Limited Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai- 400 001 Scrip Code: 543434
Dear Sir/Madam,
National Stock Exchange of India Limited Exchange Plaza, Plot no. C/1, G Block, Bandra-Kurla Complex Bandra (E), Mumbai - 400 051 NSE Symbol: SUPRIYA
Subject: Intimation of Earnings Call for quarter and half year ended September 30, 2022
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that an earnings call will be held on Friday, November 11, 2022 at 4.00 P.M. IST to discuss operational and financial performance of the Company for the quarter and half year ended September 30, 2022. The invite giving requisite details including the pre-registration link and dial-in details is attached herewith.
This intimation is also being made available on the website of the Company at: https://supriyalifescience.com/investor-relation/
Kindly take the information on record.
Thanking you,
For Supriya Lifescience Limited
Shweta Singh Company Secretary & Compliance Officer Membership No.: A44973
Corporate office
: 207/208, Udyog Bhavan, Sonawala Road, Goregaon (East), Mumbai – 400 063. Maharashtra, India. Fax : +91 22 26860011 GSTIN: 27AALCS8686A1ZX Tel: +91 22 40332727 / 66942507
CIN: L51900MH2008PLC180452 E-mail: supriya@supriyalifescience .com Website: www.supriyalifescience.com
Factory : A-5/2, Lote Parshuram Industrial Area, M.I.D.C. Tal.– Khed, Dist. – Ratnagiri, Pin :415 722, Maharashtra, India. Tel: +91 2356 272299 Fax: +91 2356 272178 E-mail: factory@supriyalifescience.com
GOVT. RECOGNISED EXPORT HOUSE
Supriya Lifescience Ltd
Cordially Invites you to Earning call To discuss operational and financial performance for Q2 & H1 FY23
Friday, 11th November 2022 at 4:00 PM, IST
Access Numbers
Pre - Registration Link - Click Here
Participants
Dr. Satish Wagh - Chairman & Managing Director
Dr. Saloni Wagh - Whole Time Director
Mr. Rajeev Kumar Jain - Chief Executive Officer
Mr. Ashish Nayak - Chief Financial Officer
Dr. Shireesh Ambhaikar - Technical Lead
Primary Number
International Toll Free Number
+91 22 6280 1550
+91 22 7115 8378
Hongkong: 800 964 448
Singapore: 800 101 2045
USA: 1 866 746 2133
UK: 0 808 101 1573
RSVP : Ms. Rasika Sawant, Orient Capital - IR
Contact / Email : +91 95944 57518/ rasika.sawant@linkintime.co.in